Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Dacarbazine and PLX4032 cross-resistance emerges via distinct ...
Model depicting signaling network changes in response to PLX4032 ...
Model illustrating the antagonism between PLX4032 and ATRA. Treatment ...
PLX4032 increases DR5 expression at the transcriptional level (A,B ...
Mannose enhances anti-tumor effect of PLX4032 in anaplastic thyroid ...
The combination of PLX4032 and AZD6244 is as effective as PLX0432 or ...
Cytotoxic potential of targeted therapeutic PLX4032 in BRAF V600E ...
PLX4032 treatment increases EMT via over-expression of PI3K/AKT pathway ...
PLX4032 reduced cell adhesion and promoted migration in BRAFWT melanoma ...
Verteporfin restores PLX4032 suppression of ERK1/2 signaling and tumor ...
ROS are induced after PLX4032 treatment of melanoma cells. a A375, 501 ...
The combination of Vitamin C and PLX4032 synergistically inhibited the ...
Effect of the combination of PLX4032 and U18666 A in LM16 R cells. (A ...
PLX4032 modulation of the MAPK pathway and melanoma cell line ...
PLX4032 (Vemurafenib)产品说明书
PLX4032 impact on A375 and A375-PLX-R cell spheroid formation and ...
PLX4032 Inhibits Raf Signaling in a V600E-dependent Manner. A panel of ...
Effects of PLX4032 on cell cycle and apoptosis. a-c) Melanoma cell ...
The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell ...
PLX4032 treatment leads to enhanced activity of several receptor ...
PLX4032 selectively inhibits phosphorylation of signaling targets in ...
Expression of MMP-1, 2, and 3 after PLX4032 treatment. (A) TPC1 cells ...
Cell cycle effects of PLX4032 and PLX4720 in thyroid cancer cells. A ...
Sensitivity of melanoma cell lines to PLX4032 a . | Download Scientific ...
All-trans Retinoic Acid Overcomes Acquired Resistance to PLX4032 via ...
PLX4032 signature and validation. (A) The heatmap columns are the ...
In vitro activity of PLX4032 in Melanoma. (A) Proliferation of V600E ...
PLX4032 inhibits incorporation of EdU selectively in mutated papillary ...
Effect of PLX4032 and GDC-0973 on MEL-XY3 cells. MEL-XY3 cells were ...
Association between acquired resistance to PLX4032 (vemurafenib) and ...
Combination of PLX4032 with inhibitors dually targeting EGFR and HER2 ...
Effect of the combination of PLX4032 and orlistat in LM16 R cells. (A ...
(A) PLX4032 induced growth inhibition in melanoma cells A375 BRAFV600E ...
PLX4032 increases RHOB expression in BRAF V600E melanoma cells. A and ...
Downregulation of BRAF signaling by PLX4032 activates AMPK by ...
Resistance to PLX4032 is independent of MEK and CRAF. (A) The ...
PLX4032 causes apoptosis selectively in mutated papillary thyroid ...
PLX4032 mediates apoptosis of BRAF mutant melanoma cell lines through ...
Docking for PLX4032 in wild type BRAF and V600E mutant binding patterns ...
Examples of PLX4032 effec
Growth rate of cells after PLX4032 treatment. TPC1 and 8505C cells ...
PLX4032 and GDC0973 combined treatment reduced the growth of BRAFV600E ...
PLX4032 inhibited the ERK-dependent transcriptional output of BRAF ...
Single agent PLX4032 resulted in activation of p-AKT Ser473 following ...
(PDF) PLX4032 resistance of patient-derived melanoma cells: crucial ...
Vitamin C sensitizes BRAFV600E thyroid cancer to PLX4032 via inhibiting ...
PLX4032 treatment induces upregulation of PDK mRNA in BRAF V600E ...
Apoptosisanalysisafter PLX4032 treatment. (A) TPC1 cells were treated ...
Cotreatment with MET inhibitor and PLX4032 inhibits growth, invasion ...
(PDF) Differential Effects of the Oncogenic BRAF Inhibitor PLX4032 ...
Cell cycle analysis after PLX4032 treatment. (A) TPC1 cells were ...
The structures of PLX4032 and PLX4720 | Download Scientific Diagram
Frontiers | PLX4032 resistance of patient-derived melanoma cells ...
PLX4032 inhibits ERK phosphorylation only in BRAF V600E -mutant cell ...
RAF kinase in response to PLX4032. (A, B, E) Immune-complex kinase ...
Vemurafenib (PLX4032) – BRAF V600E Inhibitor | APExBIO
(PDF) PLX4032, a selective BRAFV600E kinase inhibitor, activates the ...
Molecular characteristics of the PLX4032-resistant LM20 and LM38 cell ...
Identification of PLX4032-resistance mechanisms and implications for ...
PLX4032, a Potent Inhibitor of the B-Raf V600E Oncogene, Selectively ...
HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated ...
Suppression of PLX4032-resistant B-Raf(V600E) cell types by MEDICA. (A ...
Growth responses of PLX4032-resistant YUMAC cells to... | Download ...
Figure 3. | All-trans Retinoic Acid Overcomes Acquired Resistance to ...
Figure 2. | Life Science Alliance
Characterization of PLX4032-resistant melanoma cells. (A) IC50 curves ...
Selection of PLX4032-resistant variant LM17R by long- term exposure of ...
Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and ...
Identification of PLX4032‐resistance mechanisms and implications for ...
Vemurafenib (Plexxikon/Roche's Zelboraf; PLX4032) approved by the FDA ...
Potent Imidazothiazole-based Inhibitor of BRAF V600E Overcomes Acquired ...
PLX4032-induced enhancement of TRAIL-induced apoptosis in Ras-mutant ...
Cell surface CD63 increased by up‐regulated polylactosamine ...
Relief of feedback inhibition of HER3 transcription by RAF and MEK ...
Frontiers | Kisspeptin-mediated improvement of sensitivity to BRAF ...
Phospho-proteomic analyses of B-Raf protein complexes reveal new ...
Adaptive up-regulation of FOXD3 and resistance to PLX4032/4720-induced ...
